"Our “next generation” service for clinical trials is a unique value proposition of IQVIA and is an area that many of our competitors are now attempting…
In Conversation
"The company invests a lot into education with doctors, using them as a middle man between the company and the patients."
"As the premier research based company in the world, we are strongly committed to remain at the forefront of the Polish innovative landscape."
"Every year the number of innovative products entering the market is improving, despite our government placing pricing pressures on companies to lower the costs of treatment."
"The constant obstacle our clients are witnessing is the pricing pressures being placed upon them from the payers - the Ministry of Health and National health…
"Poland must adapt to the new global trend of digitalisation to remain competitive within the region and attract further investment."
"There is not a great focus in Poland on medical dermatology, and if you look at the actual amount spent in this therapeutic area, it is…
"We took the bold decision in 2012 to enter into the OTC and dietary supplements market. These areas are less regulated, and allow us to split…
"Poland has the bright minds on hand to kick start larger investments, but it also needs institutional support and must tackle legislative areas head-on to simplify…
"Companies allocate a certain proportion of funds to support our operations, such as conferences and events, though perhaps we must do more to convince them to…
"The Minister of economic development and finance, Mateusz Morawiecki, is equally attempting to find a solution to simplify the system, although, the efforts of the government…
"Poland must move towards having a more patient-centric approach of healthcare, and we want to be part of this movement."
